Dynatronics to Participate in Oppenheimer’s 29th Annual Healthcare Conference in New York, NY
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 14, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
News
DNA Dynamics, Inc. Expands Operations into the Hemp Industry
NEW YORK, NY / ACCESSWIRE / March 14, 2019 / DNA Dynamics, Inc. (OTC PINK: DNAD) announces today that they...
VistaGen Therapeutics to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19, 2019
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 14, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
DECN Launches Its Genultimate 4Pets and Avantage Meter, Ground-Breaking Products for the Testing of Dogs, Cats and Horses, Receives First Retail Orders, Establishes Innovative Rebate Program
Launch Places DECN at the Top of Tier in the Fast Growing Pet Testing Market with Both Proprietary Products and...
Aytu BioScience Announces Natesto(R) Presentations at Two Upcoming Scientific Conferences
Data to be Presented on Ongoing Natesto Spermatogenesis Study, Study Evaluating the Effect of Natesto Nasal Testosterone on Male Fertility...
CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo (TM) in Alzheimer’s Disease
ALACHUA, FL / ACCESSWIRE / March 14, 2019 / CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that...
EViTRADE Names Clean-Tech Pioneer Dr. Macarena Cataldo-Hernández to Scientific Advisory Board
VANCOUVER, BC / ACCESSWIRE / March 14, 2019 / EViTRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction
CAMPBELL, CA / ACCESSWIRE / March 14, 2019 / VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced...
Soliton Partners with Sanmina, a Global Medical Device Manufacturer
HOUSTON, TX / ACCESSWIRE / March 14, 2019 / Soliton, Inc., (NASDAQ: SOLY) (''Soliton'' or the ''Company''), a medical device...
DECN in Pact with Alpha Capital Anstalt
LOS ANGELES, CA / ACCESSWIRE / March 14, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is...
MorphoSys Presents Results for Fiscal Year 2018
Conference call and webcast (in English) tomorrow, March 14, 2019 at 2:00pm CET (1:00pm GMT/9:00am EDT)Highlights in R&D and corporate...
Savara Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update
On-Track to Report Top Line Results from Pivotal Phase 3 IMPALA Study at End of Q2 2019 AUSTIN, TX /...
Easton Announces Status Update On Its $2,600,000 Framing Contract To Construct 150 Homes, Including Update on Its Development Project in Cobourg, Ontario
TORONTO, ON / ACCESSWIRE / March 13, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Provides Update on Its $2,600,000...
CLS Holdings USA Locks Up Joint Venture Agreement with CannAssist
86,000 square foot planned cultivation facility expected to produce 28000 pounds of flower annually LAS VEGAS, NV / ACCESSWIRE /...
IntraBio Investigational New Drug Application Approved by the FDA for the Treatment of Ataxia-Telangiectasia
OXFORD, UK / ACCESSWIRE / March 13, 2019 / IntraBio Inc., a late-stage biopharmaceutical company, today announced that the US...
Orchestra BioMed(R) to Present at Oppenheimer 29th Annual Healthcare Conference
Presentation with live audio webcast on Tuesday, March 19, 2019 at 3:20 p.m. ET NEW HOPE, PA / ACCESSWIRE /...
VistaGen Therapeutics Receives Notice of Allowance for Additional U.S. Patent Regarding Methods of Production for AV-101
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 13, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Aquarius Surgical Technologies Provides an Update on its 2018 Operation Successes
NEWMARKET, ON / ACCESSWIRE / March 12, 2019 / Aquarius Surgical Technologies Inc. (CSE: ASTI) ("Aquarius" or "the Company") today...
1933 Industries Reports Results of Annual General Meeting
VANCOUVER, BC / ACCESSWIRE / March 12, 2019 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQX:...
Sterna Biologicals Holds Scientific Advisory Board Meetings to Advance Phase IIb Clinical Development Program of SB010 in Asthma
Meetings attended by key opinion leaders from the US and Europe Input provided on SB010 phase IIb clinical development program...